2 hours ago
1
Torsten Asmus/iStock via Getty Images
- Shares of TransMedics (NASDAQ:TMDX) are up on Monday after the company's CEO, Waleed H Hassanein, purchased shares of the company worth $2M.
- Hassanein bought about 16,875 shares between a price range of $116.25 and $118.68, according to SEC filings.
- The stock is trading up 12.5%.
More on TransMedics Group
- TransMedics: Continued Strength Suggests Further Upside
- TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript
- Why TransMedics Remains A Buy Into 2026
- TransMedics rises as FDA greenlights OCS heart trial
- TransMedics outlines 35% 2025 revenue growth outlook as global expansion and clinical programs accelerate
English (US) ·